SEC Form SC 13G/A filed by Deciphera Pharmaceuticals Inc. (Amendment)
$DCPH
Biotechnology: Pharmaceutical Preparations
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
DECIPHERA PHARMACEUTICALS, INC.
(Name of Issuer)
Common Stock, $0.01 par value
(Title of Class of Securities)
24344T101
(CUSIP Number)
December 31, 2023
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☒ Rule 13d-1(b)
☐ Rule 13d-1(c)
☐ Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Continued on following pages
Page 1 of 8 Pages
|
CUSIP No. 24344T101
|
|
Page 2 of 8 Pages
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
|
BRAIDWELL LP
|
|
|
|||
|
|
|
||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
|
(a)☐
|
|||||
|
(b)☐
|
|
|
|||
|
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|
|||
|
|
|
||||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
|
Delaware
|
|
|
|||
|
|
|
||||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
|
-0-
|
|
|
|||
|
|
|
||||
|
6
|
SHARED VOTING POWER
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
|
-0-
|
|
|
|||
|
|
|
||||
|
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
|
☐
|
|
|
|||
|
|
|
||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
|
2.92%2
|
|
|
|||
|
|
|
||||
|
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
|
IA, PN
|
|
|
|||
|
|
|
||||
|
1
|
Consists of 1,169,490 Shares (as defined herein) and 1,216,133 Shares issuable upon the exercise of immediately exercisable pre-funded warrants (“Warrants”), all of which are directly owned by Braidwell Partners Master Fund LP.
|
|
2
|
Based on 80,503,338 Shares outstanding as of December 31, 2023, as reported in the Issuer’s annual report on Form 10-K for the fiscal year ended December 31, 2023 filed with the Securities and Exchange Commission (the “SEC”) on
February 7, 2024, plus the 1,216,133 Shares the Reporting Persons have the right to acquire upon exercise of Warrants, which amount has been added to the Shares outstanding in accordance with Rule 13d-3(d)(1)(i) under the Act.
|
|
CUSIP No. 24344T101
|
|
Page 3 of 8 Pages
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
|
BRAIDWELL MANAGEMENT LLC
|
|
|
|||
|
|
|
||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
|
(a)☐
|
|||||
|
(b)☐
|
|
|
|||
|
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|
|||
|
|
|
||||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
|
Delaware
|
|
|
|||
|
|
|
||||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
|
-0-
|
|
|
|||
|
|
|
||||
|
6
|
SHARED VOTING POWER
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
|
-0-
|
|
|
|||
|
|
|
||||
|
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
|
☐
|
|
|
|||
|
|
|
||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
|
2.92%2
|
|
|
|||
|
|
|
||||
|
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
|
HC, OO
|
|
|
|||
|
|
|
||||
|
CUSIP No. 24344T101
|
|
Page 4 of 8 Pages
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
|
ALEXANDER T. KARNAL
|
|
|
|||
|
|
|
||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
|
(a)☐
|
|||||
|
(b)☐
|
|
|
|||
|
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|
|||
|
|
|
||||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
|
United States of America
|
|
|
|||
|
|
|
||||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
|
-0-
|
|
|
|||
|
|
|
||||
|
6
|
SHARED VOTING POWER
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
|
-0-
|
|
|
|||
|
|
|
||||
|
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
|
☐
|
|
|
|||
|
|
|
||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
|
2.92%2
|
|
|
|||
|
|
|
||||
|
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
|
IN, HC
|
|
|
|||
|
|
|
||||
|
CUSIP No. 24344T101
|
|
Page 5 of 8 Pages
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
|
BRIAN J. KREITER
|
|
|
|||
|
|
|
||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
|
(a)☐
|
|||||
|
(b)☐
|
|
|
|||
|
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|
|||
|
|
|
||||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
|
United States of America
|
|
|
|||
|
|
|
||||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
|
-0-
|
|
|
|||
|
|
|
||||
|
6
|
SHARED VOTING POWER
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
|
-0-
|
|
|
|||
|
|
|
||||
|
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
|
2,385,6231
|
|
|
|||
|
|
|
||||
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
|
☐
|
|
|
|||
|
|
|
||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
|
2.92%2
|
|
|
|||
|
|
|
||||
|
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
|
HC, OO
|
|
|
|||
|
|
|
||||
|
CUSIP No. 24344T101
|
|
Page 6 of 8 Pages
|
| Item 1(a). |
Name of Issuer:
|
Deciphera Pharmaceuticals, Inc.
| Item 1(b). |
Address of Issuer’s Principal Executive Offices:
|
200 Smith Street
Waltham, MA, 02451
| Item 2(a). |
Name of Person Filing
|
This filing is being jointly filed by Braidwell LP, Braidwell Management LLC, Alexander Karnal and Brian Kreiter (the “Reporting Persons”).
| Item 2(b). |
Address of Principal Business Office or, if None, Residence:
|
The business address of each Reporting Person is:
2200 Atlantic St
4th Floor
Stamford, CT 06902
| Item 2(c). |
Citizenship:
|
Braidwell LP is a limited partnership organized under the laws of the State of Delaware.
Braidwell Management LLC is a limited liability company organized under the laws of the State of Delaware. Alexander Karnal and Brian Kreiter are both citizens of the United States of America.
| Item 2(d). |
Title of Class of Securities:
|
Common Stock, $0.01 par value (the “Shares”)
| Item 2(e). |
CUSIP Number:
|
24344T101
| Item 3. |
If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
|
(e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E)
(g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G)
| Item 4. |
Ownership:
|
| Item 4(a). |
Amount Beneficially Owned:
|
Items 5-9 of each cover page are incorporated by reference. As of December 31, 2023, each Reporting Person may be deemed to be the beneficial owner 2,385,623 Shares, which amount consists of 1,169,490 Shares and
1,216,133 Shares issuable upon the exercise of Warrants, all of which are directly owned by Braidwell Partners Master Fund LP.
|
CUSIP No. 24344T101
|
|
Page 7 of 8 Pages
|
| Item 4(b). |
Percent of Class:
|
As of December 31, 2023, each Reporting Person may be deemed to beneficially own approximately 2.92% of the Shares, which is calculated based on 80,503,338 Shares outstanding as of December 31, 2023, as reported in the
Issuer’s annual report on Form 10-K for the fiscal year ended December 31, 2023 filed with the SEC on February 7, 2024, plus the 1,216,133 Shares the Reporting Persons have the right to acquire upon exercise of Warrants, which amount has been added
to the Shares outstanding in accordance with Rule 13d-3(d)(1)(i) under the Act.
| Item 4(c). |
Number of Shares as to which such person has:
|
| (i) |
Sole power to vote or direct the vote:
|
-0-
|
|
| (ii) |
Shared power to vote or direct the vote:
|
2,385,623
|
|
| (iii) |
Sole power to dispose or direct the disposition of:
|
-0-
|
|
| (iv) |
Shared power to dispose or direct the disposition of:
|
2,385,623
|
| Item 5. |
Ownership of Five Percent or Less of a Class:
|
If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owners of more than five percent of the class of securities, check the following ☒.
| Item 6. |
Ownership of More than Five Percent on Behalf of Another Person:
|
n/a
| Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:
|
The information in Item 4 is incorporated herein.
| Item 8. |
Identification and Classification of Members of the Group:
|
n/a
| Item 9. |
Notice of Dissolution of Group:
|
n/a
| Item 10. |
Certification:
|
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than
activities solely in connection with a nomination under §240.14a-11.
|
CUSIP No. 24344T101
|
|
Page 8 of 8 Pages
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
February 14, 2024
|
|||
|
BRAIDWELL MANAGEMENT LLC
AS GENERAL PARTNER OF BRAIDWELL LP
|
|||
|
BY:
|
/S/ MANISH K. MITAL
|
||
|
NAME: MANISH K. MITAL
|
|||
|
TITLE: AUTHORIZED SIGNATORY
|
|||
|
BRAIDWELL MANAGEMENT LLC
|
|||
|
BY:
|
/S/ MANISH K. MITAL
|
||
|
NAME: MANISH K. MITAL
|
|||
|
TITLE: AUTHORIZED SIGNATORY
|
|||
|
ALEXANDER T. KARNAL
|
|||
|
/S/ ALEXANDER T. KARNAL
|
|||
|
BRIAN J. KREITER
|
|||
|
/S/ BRIAN J. KREITER
|
|||